Shine-On BioMedical Co.,Ltd. (TPEX: 6926)
Health Care · Biotechnology · TW
NT$66.50
-1.04% today · -11.8% 1Y
Shine-On BioMedical Co.,Ltd. (TPEX: 6926) operates in the Biotechnology industry within the Health Care sector. The company is valued at $103.57M and employs 22 people.
Over the last twelve months the share price has lost 11.8%, trading between 59.90 and 77.20.
Tweenvest scores Shine-On BioMedical Co.,Ltd. across four factors: quality 42/100, value 43/100. Its strongest factor is value.
6926 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $103.57M
- Revenue (TTM)
- $1.59M
- P/E
- —
- EPS
- -3.64
- Dividend yield
- —
- Beta (5Y)
- -0.14
- 52-week high
- NT$77.20
- 52-week low
- NT$59.90
- Avg volume (3M)
- —
- Shares outstanding
- 49.80M
- Employees
- 22
- Next earnings
- —
About Shine-On BioMedical Co.,Ltd.
Shine-On BioMedical Co.,Ltd. is dedicated to the research, development, and manufacturing of pharmaceutical products aimed at combating cancer. The company's innovative pipeline features a range of antibody-based oncology therapies. These include exosome anti-cancer drugs like SOB101 and SOB102, as well as SOB201, an engineered multi-target exosome. Additionally, their portfolio encompasses specialized antibody treatments such as SOA101, a dual immune checkpoint T cell adapter, and SOA201, a trispecific adapter immune cell antibody. This Taiwanese firm, founded in 2021, is based in Taichung.
- ISIN
- TW0006926009
- Founded
- 2011
- Listed since
- Nov 25, 2022
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| BioGend Therapeutics Co., Ltd.TPEX: 6733 | $104.60M | NT$24.90 | -0.80% |
| Paradigm Biopharmaceuticals LimitedASX: PAR | $104.36M | AU$— | — |
| Corbus Pharmaceuticals Holdings, Inc.NasdaqCM: CRBP | $104.06M | $4.41 | -18.03% |
| Captor Therapeutics Spolka AkcyjnaWSE: CTX | $103.78M | zł59.60 | -6.87% |
| Inovio Pharmaceuticals, Inc.NasdaqCM: INO | $103.21M | $0.99 | -1.22% |
| ArcticZymes Technologies ASAOB: AZT | $102.98M | Nkr19.20 | +0.26% |
| Bioceltix S.A.WSE: BCX | $102.94M | zł69.20 | -5.08% |
| Kintor Pharmaceutical LimitedSEHK: 9939 | $102.88M | HK$1.64 | -8.91% |
Figures last refreshed Oct 11, 2026.